BriaCell Therapeutics Corp.

TSX:BCT.TO

Biotechnology

Healthcare
$5.75 +18.88%

+$0.94 today

Market cap
$50.02M
Beta
1.53
P/E (TTM)
-0.3
EPS (TTM)
-$4.23
52W Low $3.68High $20.40

Volume 0.00M

Average 0.01M

Balance Sheet

Inspect the capital base behind the business.

Assets

$21.72M

FY 2025 · Annual

+269.9% YoY

Liabilities

$4.33M

FY 2025 · Annual

-49.4% YoY

Equity

$17.39M

FY 2025 · Annual

Balance Sheet

USD
Metric
FY2021
Jul 2021
FY2022
Jul 2022
FY2023
Jul 2023
FY2024
Jul 2024
FY2025
Jul 2025
Cash & Equivalents57.27M41.04M21.25M862.09K10.53M
Short-term Investments00007.4M
Net Receivables12.57K24.1K717.74K1.37M566.73K
Inventory00000
Other Current Assets00000
Total Current Assets57.8M42.35M26.95M3.65M19.99M
Property, Plant & Equipment (Net)000388.18K297.84K
Goodwill00000
Intangible Assets245.61K230.34K215.07K199.8K185.16K
Long-term Investments000418.49K526.07K
Tax Assets00000
Other Non-current Assets0001.21M719.97K
Total Non-current Assets245.61K230.34K215.07K2.22M1.73M
Total Assets58.04M42.58M27.16M5.87M21.72M
Account Payables214.12K463.28K1.12M7.17M3.29M
Short-term Debt00000
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities0000696.66K
Total Current Liabilities556.8K941.09K1.8M7.46M3.99M
Long-term Debt25.99K0000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities29.79M31.31M29.14M1.1M338.83K
Total Non-current Liabilities29.82M31.31M29.14M1.1M338.83K
Total Liabilities30.37M32.25M30.94M8.56M4.33M
Common Stock54.77M65.59M69.59M72.17M102.09M
Retained Earnings(29.14M)(60.35M)(80.65M)(85.44M)(112.14M)
Accumulated OCI(138.68K)(138.68K)(138.68K)(138.68K)27.99M
Other Stockholders Equity00011.03M0
Minority Interest000(302.52K)(548.67K)
Total Equity27.67M10.33M(3.78M)(2.68M)17.39M
Total Debt25.99K0000
Net Debt(57.24M)(41.04M)(21.25M)(862.09K)(10.53M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$6.9M
Short-term Investments$15.9M
Receivables$2.6M
Total Current Assets$25.4M
PP&E (Net)$349.0K
Intangible Assets$173.3K
Long-term Investments$751.0K
Other Non-current$404.9K
Total Non-current Assets$1.7M
Total Assets$27.1M

Analysis

Selected assets total $27.1M for Latest. The largest visible component is Short-term Investments at $15.9M, about 58.8% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Competitors

Peer companies in the same sector

Health

No competitor data available.

Recent Filings

Recent regulatory filings

No filings found.

How much cash does BCT.TO have?

BriaCell Therapeutics Corp. (BCT.TO) reported $10.53M in cash and equivalents in fiscal 2025.

How much debt does BCT.TO carry?

BriaCell Therapeutics Corp. (BCT.TO) reported $0.00 of total debt, with net debt of -$10.53M.